Skip to main content

READYSTATE ASSET MANAGEMENT LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1900923 CHICAGO, IL

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
10 quarters on record

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026
CallValue
$645,749
CallShares
1,300
PutValue
$1,043,133
PutShares
2,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

READYSTATE ASSET MANAGEMENT LP holds $170,733,904 across 15 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in VRTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $645,749 1,300
2026-06-30 $1,043,133 2,100
2026-03-31 $357,232 800
2026-03-31 $714,464 1,600
2025-03-31 $2,666,510 5,500
2025-03-31 $3,296,776 6,800
2024-12-31 $7,772,110 19,300
2024-12-31 $4,453,056 11,058
2024-12-31 $6,402,930 15,900
2024-09-30 $2,862,102 6,154
2024-09-30 $16,184,784 34,800
2024-09-30 $8,278,424 17,800
2024-06-30 $749,952 1,600
2024-06-30 $703,080 1,500
2024-03-31 $407,141 974
2024-03-31 $14,295,942 34,200
2024-03-31 $12,122,290 29,000
2023-12-31 $3,865,455 9,500
2023-12-31 $5,696 14
2023-12-31 $3,865,455 9,500
2023-09-30 $208,644 600
2023-09-30 $208,644 600
2023-06-30 $211,146 600
2023-06-30 $211,146 600